1559 related articles for article (PubMed ID: 8593812)
21. Induction of vasoactive intestinal peptide gene expression and prolactin secretion by insulin-like growth factor I in rat pituitary cells: evidence for an autoparacrine regulatory system.
Lara JI; Lorenzo MJ; Cacicedo L; Tolón RM; Balsa JA; López-Fernández J; Sánchez-Franco F
Endocrinology; 1994 Dec; 135(6):2526-32. PubMed ID: 7988440
[TBL] [Abstract][Full Text] [Related]
22. Suppressed tyrosine hydroxylase gene expression in the tuberoinfundibular dopaminergic system during lactation.
Wang HJ; Hoffman GE; Smith MS
Endocrinology; 1993 Oct; 133(4):1657-63. PubMed ID: 8104777
[TBL] [Abstract][Full Text] [Related]
23. Preferential increase in pituitary prolactin versus vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat.
Carrillo AJ; Doherty PC; Guan XB; Sturtevant JR; Walro DG
Endocrinology; 1991 Jan; 128(1):131-8. PubMed ID: 1986914
[TBL] [Abstract][Full Text] [Related]
24. Estrogen regulates the gene expression of vasoactive intestinal peptide in the anterior pituitary.
Lam KS; Srivastava G; Lechan RM; Lee T; Reichlin S
Neuroendocrinology; 1990 Nov; 52(5):417-21. PubMed ID: 2126350
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of prolactin release and lactotrope proliferation during pregnancy, lactation and the estrous cycle.
Yin P; Arita J
Neuroendocrinology; 2000 Aug; 72(2):72-9. PubMed ID: 10971142
[TBL] [Abstract][Full Text] [Related]
26. Hypothalamic vasoactive intestinal peptide messenger ribonucleic acid is increased in lactating rats.
Gozes I; Shani Y
Endocrinology; 1986 Dec; 119(6):2497-501. PubMed ID: 3780537
[TBL] [Abstract][Full Text] [Related]
27. Neuropeptide Y and tuberoinfundibular dopamine activities are altered during lactation: role of prolactin.
Li C; Chen P; Smith MS
Endocrinology; 1999 Jan; 140(1):118-23. PubMed ID: 9886815
[TBL] [Abstract][Full Text] [Related]
28. Expression of D1 and D2 dopamine receptors in the hypothalamus and pituitary during the turkey reproductive cycle: colocalization with vasoactive intestinal peptide.
Chaiseha Y; Youngren O; Al-Zailaie K; El Halawani M
Neuroendocrinology; 2003 Feb; 77(2):105-18. PubMed ID: 12624532
[TBL] [Abstract][Full Text] [Related]
29. Suckling-induced changes of vasoactive intestinal peptide concentrations in hypothalamic areas implicated in the control of prolactin release.
Chiocchio SR; de las Nieves Parisi M; Vitale ML; Tramezzani JH
Neuroendocrinology; 1991 Jul; 54(1):77-82. PubMed ID: 1922680
[TBL] [Abstract][Full Text] [Related]
30. Vasoactive intestinal peptide stimulates prolactin mRNA expression in turkey pituitary cells: effects of dopaminergic drugs.
Xu M; Proudman JA; Pitts GR; Wong EA; Foster DN; el Halawani ME
Proc Soc Exp Biol Med; 1996 May; 212(1):52-62. PubMed ID: 8618952
[TBL] [Abstract][Full Text] [Related]
31. Posterior pituitary lobectomy abolishes the suckling-induced rise in prolactin (PRL): evidence for a PRL-releasing factor in the posterior pituitary.
Murai I; Ben-Jonathan N
Endocrinology; 1987 Jul; 121(1):205-11. PubMed ID: 3496207
[TBL] [Abstract][Full Text] [Related]
32. Reduced dopaminergic tone during lactation is permissive to the hypothalamic stimulus for suckling-induced prolactin release.
Silva KSC; Aquino NSS; Gusmao DO; Henriques PC; Reis AM; Szawka RE
J Neuroendocrinol; 2020 Nov; 32(11):e12880. PubMed ID: 32627906
[TBL] [Abstract][Full Text] [Related]
33. Vasoactive intestinal polypeptide antiserum affects rat prolactin mRNA in 40-day but not 110-day diethylstilbestrol-induced prolactinoma tissue.
Maas DL; Meier DA; Wahle JS; Martinson DR; Hagen TC
Mol Cell Neurosci; 1994 Apr; 5(2):182-8. PubMed ID: 8032686
[TBL] [Abstract][Full Text] [Related]
34. Dopamine transporters participate in the physiological regulation of prolactin.
Demaria JE; Nagy GM; Lerant AA; Fekete MI; Levenson CW; Freeman ME
Endocrinology; 2000 Jan; 141(1):366-74. PubMed ID: 10614659
[TBL] [Abstract][Full Text] [Related]
35. Alterations in hypothalamic vasoactive intestinal peptide-like immunoreactivity are associated with reproduction and prolactin release in the female turkey.
Mauro LJ; Elde RP; Youngren OM; Phillips RE; el Halawani ME
Endocrinology; 1989 Oct; 125(4):1795-804. PubMed ID: 2676472
[TBL] [Abstract][Full Text] [Related]
36. Age-related changes in gonadal and serotonergic axes of broiler breeder roosters.
Avital-Cohen N; Heiblum R; Argov-Argaman N; Rosenstrauch A; Chaiseha Y; Mobarkey N; Rozenboim I
Domest Anim Endocrinol; 2013 Apr; 44(3):145-50. PubMed ID: 23411011
[TBL] [Abstract][Full Text] [Related]
37. The peak phase of the proestrous prolactin surge is blocked by either posterior pituitary lobectomy or antisera to vasoactive intestinal peptide.
Murai I; Reichlin S; Ben-Jonathan N
Endocrinology; 1989 Feb; 124(2):1050-5. PubMed ID: 2492217
[TBL] [Abstract][Full Text] [Related]
38. Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion.
Samson WK; Bianchi R; Mogg RJ; Rivier J; Vale W; Melin P
Endocrinology; 1989 Feb; 124(2):812-9. PubMed ID: 2912703
[TBL] [Abstract][Full Text] [Related]
39. Studies on the role of TRH and corticosterone in the regulation of prolactin and thyrotrophin secretion during lactation.
van Haasteren GA; van Toor H; Klootwijk W; Handler B; Linkels E; van der Schoot P; van Ophemert J; de Jong FH; Visser TJ; de Greef WJ
J Endocrinol; 1996 Feb; 148(2):325-36. PubMed ID: 8699147
[TBL] [Abstract][Full Text] [Related]
40. Implication of pituitary vasoactive intestinal peptide in dopaminergic inhibition of estrogen-induced pituitary hyperplasia and vascular endothelial growth factor expression.
Gómez O; Balsa JA
Neuroendocrinology; 2004; 80(5):324-31. PubMed ID: 15677882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
